肝细胞癌血管动力学的超声造影定量评估用于LI-RADS实施
前瞻性单中心研究纳入31例肝细胞癌患者,采用超声造影采集≥2个5分钟动态环并自动呼吸门控与运动补偿,对时间-强度曲线线性化后提取上升时间与消退程度参数。结果显示所有病灶上升时间短于周围肝实质(P<0.05),2分钟和5分钟均可见程度不等的消退(P<0.05),上升时间变异系数11%,消退程度与相对消退程度变异系数22%~31%。作者认为该方案可定量描述LI-RADS 5类肝细胞癌的血管动态模式。
要点
- 超声造影时间-强度曲线线性化后可提取上升时间(RT)与消退程度(DW)定量参数。
- 肝细胞癌病灶RT短于周围肝实质(P<0.05),2分钟和5分钟均可见显著但程度不等的消退(P<0.05)。
- RT变异系数11%,DW与相对消退程度(rDW)在2分钟和5分钟变异系数22%~31%。
核心结论
- 所提出的成像方案与分析方法可提供稳健的定量指标,描述经分类为肝细胞癌的LI-RADS 5类病灶的动态血管模式,首次以可定量方式实施CEUS LI-RADS并去除其现有定性及主观评价问题。
研究设计与样本
- 前瞻性单中心研究,2021年4月至2022年6月纳入31例肝细胞癌患者(平均年龄67±6岁,24男/7女),使用关节臂固定探头对每个病灶不同扫描切面采集至少2个跨度超过5分钟的超声造影动态环,采用自动呼吸门控与运动补偿算法去除呼吸运动误差。
关键影像表现/征象
- 所有病灶的上升时间(RT)短于周围肝实质,反映动脉期高增强(P<0.05)。
- 所有病灶在2分钟和5分钟时间点均显示显著但程度不等的消退(P<0.05),以相对消退程度(rDW)定量。
- 病灶与周围肝实质的RT变异系数均为11%,DW与rDW在2分钟和5分钟的变异系数范围为22%~31%。
- 病灶与肝实质RT之间、病灶RT与病灶DW在2分钟和5分钟时间点之间均存在统计学显著关系(P<0.05)。
诊断标准与关键数值
- 病灶长轴在造影与基波图像上测量以获取结节大小,平均±标准差病灶直径为23±8 mm。
- 对每个病灶的病灶与肝实质RT行Welch t检验以确认统计学显著差异(P<0.05)。
- 计算相对消退程度(rDW,病灶与周围肝实质DW比值)的自举95%置信区间P值以量化病灶消退。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study is to describe a comprehensive contrast-enhanced ultrasound (CEUS) imaging protocol and analysis method to implement CEUS LI-RADS (Liver Imaging Reporting and Data System) in a quantifiable manner. The methods that are validated with a prospective single-center study aim to simplify CEUS LI-RADS evaluation, remove observer bias, and potentially improve the sensitivity of CEUS LI-RADS.
MATERIALS AND METHODS: This prospective single-center study enrolled patients with hepatocellular carcinoma (April 2021-June 2022; N = 31; mean age ± SD, 67 ± 6 years; 24 men/7 women). For each patient, at least 2 CEUS loops spanning over 5 minutes were collected for different lesion scan planes using an articulated arm to hold the transducer. Automatic respiratory gating and motion compensation algorithms removed errors due to breathing motion. The long axis of the lesion was measured in the contrast and fundamental images to capture nodule size. Parametric processing of time-intensity curve analysis on linearized data provided quantifiable information of the wash-in and washout dynamics via rise time ( RT ) and degree of washout ( DW ) parameters extracted from the time-intensity curve, respectively. A Welch t test was performed between lesion and parenchyma RT for each lesion to confirm statistically significant differences. P values for bootstrapped 95% confidence intervals of the relative degree of washout ( rDW ), ratio of DW between the lesion and surrounding parenchyma, were computed to quantify lesion washout. Coefficient of variation (COV) of RT , DW , and rDW was calculated for each patient between injections for both the lesion and surrounding parenchyma to gauge reproducibility of these metrics. Spearman rank correlation tests were performed among size, RT , DW , and rDW values to evaluate statistical dependence between the variables.
RESULTS: The mean ± SD lesion diameter was 23 ± 8 mm. The RT for all lesions, capturing arterial phase hyperenhancement, was shorter than that of surrounding liver parenchyma ( P < 0.05). All lesions also demonstrated significant ( P < 0.05) but variable levels of washout at both 2-minute and 5-minute time points, quantified in rDW . The COV of RT for the lesion and surrounding parenchyma were both 11%, and the COV of DW and rDW at 2 and 5 minutes ranged from 22% to 31%. Statistically significant relationships between lesion and parenchyma RT and between lesion RT and lesion DW at the 2- and 5-minute time points were found ( P < 0.05).
CONCLUSIONS: The imaging protocol and analysis method presented provide robust, quantitative metrics that describe the dynamic vascular patterns of LI-RADS 5 lesions classified as hepatocellular carcinomas. The RT of the bolus transit quantifies the arterial phase hyperenhancement, and the DW and rDW parameters quantify the washout from linearized CEUS intensity data. This unique methodology is able to implement the CEUS-LIRADS scheme in a quantifiable manner for the first time and remove its existing issues of currently being qualitative and suffering from subjective evaluations.
引用
- Krolak C, Dighe M, Clark A, et al. Quantification of Hepatocellular Carcinoma Vascular Dynamics With Contrast-Enhanced Ultrasound for LI-RADS Implementation. Invest Radiol. 2023. PMID: 37725492. doi:10.1097/RLI.0000000000001022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。